Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Crosby

Showing results (171-180 of 181) with videos related to

Pageof 19
Sort By:
Cancer|December 11, 2014
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes projectBouthaina S Dabaja, Ann M Vanderplas, Allison L Crosby-Thompson, et al.
Cancer|August 8, 2013
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes projectAndrew M Evens, Ann Vanderplas, Ann S LaCasce, et al.
Blood|January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL DatabaseAnn S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
British Journal of Haematology|October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseMakiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
Genomics|September 24, 1999
Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16qB J Loftus, U J Kim, V P Sneddon, et al.
BMJ Health & Care Informatics|April 14, 2021
Infrastructure and operating processes of PIONEER, the HDR-UK Data Hub in Acute Care and the workings of the Data Trust Committee: a protocol paperSuzy Gallier, Gary Price, Hina Pandya, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialSomnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
Science (New York, N.Y.)|August 2, 2003
Genome-wide insertional mutagenesis of Arabidopsis thalianaJosé M Alonso, Anna N Stepanova, Thomas J Leisse, et al.
Pageof 19

Showing results (171-180 of 181) with videos related to

Sort By:
Pageof 19
Cancer|December 11, 2014
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes projectBouthaina S Dabaja, Ann M Vanderplas, Allison L Crosby-Thompson, et al.
Cancer|August 8, 2013
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes projectAndrew M Evens, Ann Vanderplas, Ann S LaCasce, et al.
Blood|January 12, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL DatabaseAnn S LaCasce, Jonathan L Vandergrift, Maria A Rodriguez, et al.
British Journal of Haematology|October 12, 2013
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes databaseMakiko Ban-Hoefen, Ann Vanderplas, Allison L Crosby-Thompson, et al.
Eclinicalmedicine|July 6, 2023
Efficacy of early PET-CT directed switch to carboplatin and paclitaxel based definitive chemoradiotherapy in patients with oesophageal cancer who have a poor early response to induction cisplatin and capecitabine in the UK: a multi-centre randomised controlled phase II trialSomnath Mukherjee, Christopher N Hurt, Richard Adams, et al.
Genomics|September 24, 1999
Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16qB J Loftus, U J Kim, V P Sneddon, et al.
BMJ Health & Care Informatics|April 14, 2021
Infrastructure and operating processes of PIONEER, the HDR-UK Data Hub in Acute Care and the workings of the Data Trust Committee: a protocol paperSuzy Gallier, Gary Price, Hina Pandya, et al.
European Journal of Cancer (Oxford, England : 1990)|June 22, 2021
Oxaliplatin/capecitabine or carboplatin/paclitaxel-based preoperative chemoradiation for resectable oesophageal adenocarcinoma (NeoSCOPE): Long-term results of a randomised controlled trialSomnath Mukherjee, Christopher Hurt, Ganesh Radhakrishna, et al.
Eclinicalmedicine|October 3, 2022
Use of a non-endoscopic immunocytological device (Cytosponge™) for post chemoradiotherapy surveillance in patients with oesophageal cancer in the UK (CYTOFLOC): A multicentre feasibility studyChristopher M Jones, Heather O'Connor, Maria O'Donovan, et al.
Science (New York, N.Y.)|August 2, 2003
Genome-wide insertional mutagenesis of Arabidopsis thalianaJosé M Alonso, Anna N Stepanova, Thomas J Leisse, et al.
Pageof 19